NLS Pharma raised €2.7M in a funding round in Apr 2025. The company is based in Stans, Netherlands. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
